Treatment with Entresto (the combination of sacubitril and valsartan, formerly known as LCZ 696) instead of an ACE inhibitor will add approximately one to two years of life for most people taking the drug, according to new estimates published in the New England Journal of Medicine. Because of the time and population limitations of clinical trials it…
PARADIGM Investigators Estimate Entresto Prolongs Life by 1-2 Years
December 2, 2015 by Leave a Comment
Growing Problem: When Should Drugs Be Discontinued?
September 8, 2015 by Leave a Comment
There is an entire medical-industrial complex devoted to discovering and testing drugs to treat cardiovascular disease. Unfortunately there is a near complete absence of efforts to figure out if and when these same drugs should be discontinued. Consider Desmond Julian. The very distinguished cardiologist has been nearly killed by his profession on multiple occasions. In a State-of-the-Art…
Recent Comments